ENDRA Life Sciences Inc. (NDRA) › Weighted Average Diluted SharesENDRA Life Sciences Inc. (NDRA) — Weighted Average Diluted SharesAnnual figures by period end, from SEC filings.2023-12-31: 3.6K2024-12-31: 202.1K2025-12-31: 787.0K787.0K2023-12-31Weighted Average Diluted Shares (shares)2025-12-31Period endedWeighted Average Diluted SharesChange YoYSource filing2025-12-31787.0K+289.4%2026-03-31From 2025-01-012024-12-31202.1K+5458.5%2026-03-31From 2024-01-012023-12-313.6K—2025-04-07From 2023-01-01Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareEPS (Basic)